Histiocytosis
MONDO:0002637A morphologic finding indicating tissue infiltration by non-neoplastic or neoplastic histiocytes.
Also known as: histiocytic infiltrate, histiocytic syndrome, histiocytic and dendritic cell neoplasms
74 clinical trials for this condition and its sub-types, 16 tagged with Histiocytosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Histiocytosis
-
Langerhans cell histiocytosis 39 trials · 40 incl. sub-types
8 sub-types
- Langerhans cell histiocytosis specific to childhood 1 trial Sub-types →
- Langerhans cell histiocytosis specific to adulthood 0 trials Sub-types →
- Eosinophilic granuloma 0 trials Sub-types →
- Hand-Schuller-Christian disease 0 trials
- Multisystem langerhans cell histiocytosis 0 trials
- Pulmonary langerhans cell histiocytosis 0 trials
- Single-system multifocal langerhans cell histiocytosis 0 trials
- Unifocal langerhans cell histiocytosis 0 trials
-
Non-Langerhans cell histiocytosis 1 trial · 39 incl. sub-types
15 sub-types
- Niemann-Pick disease 10 trials · 22 incl. sub-types Sub-types →
- Erdheim-Chester disease 14 trials
- Sinus histiocytosis with massive lymphadenopathy 11 trials Sub-types →
- Juvenile xanthogranuloma 4 trials
- Indeterminate dendritic cell tumor 1 trial
- Xanthogranuloma 1 trial Sub-types →
- Benign cephalic histiocytosis 0 trials
- Generalized eruptive histiocytosis 0 trials
- Hereditary progressive mucinous histiocytosis 0 trials
- Multicentric reticulohistiocytosis 0 trials
- Necrobiotic xanthogranuloma 0 trials
- Papular xanthoma 0 trials
- Progressive nodular histiocytosis 0 trials
- Sea-blue histiocyte syndrome 0 trials
- Xanthoma disseminatum 0 trials
-
Malignant histiocytosis 3 trials
-
ALK+ histiocytosis 0 trials
-
Reticulohistiocytic granuloma 0 trials
Most studied deeper sub-types
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused Stopped earlyThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC